People in the news, July 23, 2007

Herron heads to First Round

VC blogger Christine Herron has left Omidyar Network, where she was an investment director. Herron tells PE Week via an email that she has taken an “interim role with First Round Capital—‘venture advisor’—while working on independent projects/projects with other investors.” Herron writes a popular tech blog called

Gladney joins Norwest Equity

Dan Gladney has joined Norwest Equity Partners as an operating partner focused on the health care market. He currently serves as co-founder and part-time CEO of Heartleaflet Technologies, which is developing a percutaneous aortic heart valve system. He previously was president and CEO of Compex Technologies.

MacKenzie leaves atlas for Polaris

Don MacKenzie has joined Polaris Venture Partners as CFO. He previously served as COO with Atlas Venture.

Scaturro scoots over to Goldman Sachs

Former U.S. Trust CEO Peter Scaturro has joined Goldman Sachs Group Inc. as global head of its private wealth management business. Reuters was first to report the people move last week, citing an internal memo. Scaturro, who is 47, left New York-based private wealth manager U.S. Trust before it was acquired by Bank of America Corp. from Charles Schwab Corp. in a deal that closed earlier this month.

Aurora promotes two

The Aurora Funds

has promoted both Chris Kroeger and Grant Jackson to the position of partner. Kroeger joined Aurora in September 2003 as an associate and was promoted to principal in 2005. Jackson joined Aurora in May 2004 as a senior associate and was promoted to principal in 2005. The firm is currently investing from a $75 million early stage fund that it raised in 2005.

Carver joins DLA

Ian Carver

has joined DLA Piper in the firm’s Boston office as a regional manager of its venture pipeline group. Before joining DLA Piper, Carver spent the past eight years as a director at PricewaterhouseCoopers.

Molowa joins MPM

David Molowa

has joined MPM BioEquities as a general partner based in New York. He previously was with Venrock and served as a strategic advisor to Amgen. MPM BioEquities is a private fund that invests in public and private biotech companies.